





Especially in the care of premature neonates, the regular measurement of oxygen content in the blood and tissues is tremendously important for the implementation of correct and rapid therapies. Up to now, it was quite difficult and painful, to extract a sufficient amount of blood for a laboratory test from a premature baby. haemospect® represents a major advancement here - and continuous measurements pose no problems either.
haemospect® also facilitates emergency interventions: here too, a rapid, reliable diagnosis can save lives or prevent organ damage caused by late complications.
A sensor head placed on the skin projects a white light into the underlying tissue via a waveguide. Some of the projected light is absorbed by the various components of tissue, while some of it is reflected.
Another waveguide transmits the light reflected as a result of the physical conditions back to the device. A spectrometer breaks the light down into its separate wavelengths and an electronic evaluation unit connected to the system analyses it.
The resulting data is then processed using an algorithm developed by MBR and visualised on the display of the device in the form of quantitative values measured for the parameters described above. Individual measurements and continuous measurements can also be carried out online. The device is powered by batteries. A matching intelligent charger is included, so the batteries will not be overloaded. With fully charged batteries, the device can measure for at least five hours in continuous operation.
MBR Optical Systems
GmbH & Co. KG
Hölker Feld 5
D-42279 Wuppertal
Tel. +49 (0)202 / 64 74 - 550
Fax +49 (0)202 / 64 74 - 560
mbr@mbr-os.com
www.mbr-optical-systems.com